期刊文献+

检测N末端脑钠肽在不典型的川崎病早期诊断的作用 被引量:2

Effect of N-terminal pro-brain natriuretic peptide detection in early diagnosis of atypical Kawasaki disease
下载PDF
导出
摘要 目的探讨N末端脑钠肽在不典型的川崎病早期诊断中的作用。方法回顾性分析10例川崎病小儿的临床资料,其中症状不典型的川崎病6例(症状不典型组)、症状典型的川崎病4例(症状典型组),同时选取发热5 d以上小儿6例作为对照组。入院时取静脉血,按规定检测N末端脑钠肽,并作心脏彩色B超检查。治疗10 d后进行复测。结果症状不典型组和症状典型组患儿的N末端脑钠肽检测值均呈不同程度的升高;对照组小儿N末端脑钠肽检测值未见升高。川崎病组明显高于对照组,差异具有统计学意义(P<0.01)。治疗10 d后进行复测,川崎病组的N末端脑钠肽检测值均呈现不同程度的下降或降至正常,与治疗前比较,差异均具有统计学意义(P<0.05)。结论检测N末端脑钠肽有助于早期诊断症状不典型的川崎病,并有助于评估病情和指导治疗,协助早期防治冠状动脉病变,值得临床推广应用。 Objective To investigate effect of N-terminal pro-brain natriuretic peptide in early diagnosis of atypical Kawasaki disease. Methods Clinical data of 10 children with Kawasaki disease were retrospectively analyzed. There were 6 cases with atypical Kawasaki disease (atypical symptom group) and 4 cases with typical Kawasaki disease (typical symptom group). Another 6 children with fever for over 5 d were taken as control group. N-terminal pro-brain natriuretic peptide was detected in venous blood taken during their admission. They received heart color B ultrasound. Reexamination was made after 10 d of treatment. Results N-terminal pro-brain natriuretic peptide had different levels of increase in both atypical symptom group and typical symptom group, while the control group had no increased value. Kawasaki disease groups had much higher value than the control group, and their difference had statistical significance (P〈0.01). Reexamination after 10 d of treatment showed that N-terminal pro-brain natriuretic peptide had different levels of decrease in Kawasaki disease groups. Compared with those before treatment, their differences all had statistical significance (P〈0.05). Conclusion Detection of N-terminal pro-brain natriuretic peptide is helpful for early diagnosis of atypical Kawasaki disease. This method is also helpful to evaluating disease and guiding treatment, as well as early preventing coronary artery disease. It is worthy of clinical promotion and application.
出处 《中国现代药物应用》 2015年第14期6-7,共2页 Chinese Journal of Modern Drug Application
关键词 N末端脑钠肽 不典型 川崎病 早期诊断 N-terminal pro-brain natriuretic peptide Atypical Kawasaki disease Early diagnosis
  • 相关文献

参考文献6

二级参考文献44

  • 1王琍,林毅,苏英姿,汪芸,赵地,吴铁吉.283例川崎病的临床分析[J].中华儿科杂志,2004,42(8):609-612. 被引量:84
  • 2武育蓉,陈树宝,黄美蓉,张玉奇,孙锟,陈笋.氨基末端脑利钠肽前体在室间隔缺损合并心力衰竭诊断中的价值[J].中华儿科杂志,2005,43(3):161-164. 被引量:37
  • 3张永兰,杜忠东.小儿川崎病冠状动脉损伤的危险因素[J].中国实用儿科杂志,2006,21(10):742-744. 被引量:48
  • 4张清友,杜军保,陈永红,李万镇.N末端脑利钠肽原在川崎病患儿中的变化及其意义[J].中华儿科杂志,2006,44(12):886-890. 被引量:28
  • 5Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease. Pediatr Int, 2005,47 ( 2 ) : 232-234.
  • 6Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Associa- tion. Circulation, 2004, 110(17) :2747-2771.
  • 7Kawamura T, Wago M, Kawaguchi H, et al. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int,2000,42(3) :241-248.
  • 8Honkanen V E, MeCrindle B W, Laxer R M, et al. Clinical relevance of the risk factory for coronary artery inflammation in Kawasaki disease [ J ]. Pediatr Cardiol, 2003, 24 ( 2 ) : 122.
  • 9Gundogda F, Bozkurt E, Kizihune A, et al. The effect of betablocker (carvedilol) therapy on N - terminal por- brain natriuertic peptid levels and eehocardiographie findings in patients with eongestiveheart failure [ J ]. Echocardiography, 2007, 24(2): 113.
  • 10Kawamura T, Wago M, Kawaguchi H, et al. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease[J]. Pediatr Int, 2000, 42: 241.

共引文献43

同被引文献9

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部